"10.1371_journal.pone.0135908","plos one","2015-08-19T00:00:00Z","Claire H den Hoedt; Muriel P C Grooteman; Michiel L Bots; Peter J Blankestijn; Ingeborg van der Tweel; Neelke C van der Weerd; E Lars Penne; Albert H A Mazairac; Renée Levesque; Piet M ter Wee; Menso J Nubé; Marinus A van den Dorpel; CONTRAST investigators","Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands; Institute for Cardiovascular Research VU Medical Center (ICaR-VU), VU Medical Center, Amsterdam, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Academic Medical Center, Amsterdam, The Netherlands; Medical Center Alkmaar, Alkmaar, The Netherlands; Centre Hospitalier de l’Université de Montréal, St. Luc Hospital, Montréal, Canada","Conceived and designed the experiments: MG MB PB PW MN MD. Performed the experiments: MG PB PW MN MD CH EP NW AM RL. Analyzed the data: CH MB IT. Contributed reagents/materials/analysis tools: CH MG MB PB PW MN MD IT EP NW AM RL. Wrote the paper: CH MG MB PB PW MN MD IT EP NW AM RL.","We have the following interests: This study was funded in part by Fresenius Medical Care (The Netherlands), Gambro Lundia AB (Sweden) and Roche Netherlands. Muriel PC Grooteman reports to be under negotiation for grant support from Fresenius Medical Care and reports receiving lecture fees from Fresenius Medical Care BV, The Netherlands. Pieter M ter Wee reports consulting support by Amgen and Sanofi and grant support from the Dutch Kidney Foundation. Menso J Nubé reports to be under negotiation for grant support from Fresenius Medical Care. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2015","08","Claire H den Hoedt","CHDH",13,TRUE,6,10,3,12,TRUE,TRUE,TRUE,1,"13",TRUE
